Center for Virology and Vaccine Research (CVVR)
  • Home
  • Research
  • Investigators
  • Instructors
  • Education
  • Publications
  • Clinical Trials Unit
  • News & Events
  • Calendar
  • Contact
  • Search
  • Menu Menu

J&J Vaccine Highly Effective Against Delta Variant in South African Trial

2021-08-06/in News

Study finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/10/wsj.jpg 400 400 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2021-08-06 09:30:142021-08-09 09:31:11J&J Vaccine Highly Effective Against Delta Variant in South African Trial

Prinicpal Investigators

Malika Aid-Boudries, Ph.D.

Dan H. Barouch, M.D., Ph.D.

Ai-ris Yonekura Collier, M.D.

Raphael Dolin, M.D.

Alan N. Engelman, Ph.D.

Sizun Jiang,Ph.D.

Boris Juelg, M.D., Ph.D.

R. Keith Reeves, Ph.D.

Sampa Santra, Ph.D.

Joern E. Schmitz, M.D.

Michael Seaman, Ph.D.

Omar K. Siddiqi, M.D., M.P.H.

Kathryn E. Stephenson, M.D., M.P.H.

C. Sabrina Tan, M.D.

CVVR

Center for Virology and Vaccine Research

3 Blackfan Circle
Boston, MA 02115 – USA

T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu

CVVR Clinical Trials Unit

T 617.735.4610
E CVVRtrials@bidmc.harvard.edu

Affiliates

Beth Israel Deaconess Medical Center

Harvard University School of Medicine

Participate in Clinical Studies
© Copyright Center for Virology and Vaccine Research. All rights reserved. Site by Academic Web Pages
  • Login
Scroll to top